🇺🇸 FDA
Patent

US 8227555

Hydrolytically stable maleimide-terminated polymers

granted A61KA61K47/60

Quick answer

US patent 8227555 (Hydrolytically stable maleimide-terminated polymers) held by Nektar Therapeutics expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/60